Anterior Cingulate Glutamate–Glutamine Levels Predict Symptom Severity in Women With Obsessive–Compulsive Disorder
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Objective: Abnormalities of the anterior cingulate cortex (ACC) have consistently been identified in obsessive–compulsive disorder (OCD), but very few studies have examined the biochemical basis of such changes. The purpose of the present study was to investigate how ACC biochemistry in OCD varies as a function of gender, hemisphere, subregion, and symptomatology. Method: 3 T proton-magnetic resonance spectroscopy (MRS) was used to probe ACC biochemistry in 20 OCD patients (10 male, 10 female) and a comparable group of 26 healthy comparison subjects. Data were acquired from the left and right dorsal and rostral subregions of the ACC. Metabolites assessed included N-acetylaspartate (NAA), glutamate–glutamine (Glx), choline-containing compounds (Cho), creatine/phosphocreatine (Cr), and myoinositol-containing compounds (mI). Results: Female OCD patients had significantly reduced levels of Glx in all but one subregion of the ACC when compared to matched controls. Levels of Glx were correlated with clinical measures of symptom severity in female but not male patients. State levels of anxiety and depression did not explain this association. In addition, both male and female OCD patients had relatively higher concentrations of mI in their right ACC (rostral and dorsal) compared with healthy controls. No other compounds had any statistically significant group differences, nor were the concentrations of any other compounds correlated with symptom measures. Conclusions: To the authors’ knowledge this is the first study to demonstrate gender-specific neurochemical changes in OCD. Although these findings are tentative and require replication, they raise the possibility that MRS techniques may be of use in objectively monitoring patient progress and assessing the effectiveness of various treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“female OCD patients had a significantly reduced concentration of glutamate–glutamine in subareas of the ACC. In addition, male and female OCD patients had higher concentrations of myoinositol-containing compounds in their right rostral and dorsal ACC”
From The neurobiological link between OCD and ADHD (2014) · cites this paper as Yucel et al. 2008
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Cognitive and emotional influences in anterior cingulate cortex
Bush, G., Luu, P., & Posner, M. I. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01483-2 · Cited by 6,259 · cited 2×
“Given that the ACC is a functionally heterogeneous region [16], subtle, regionally specific, alterations may be obscured unless key subregions are assessed independently.”
BackgroundStructured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 4,086
Estimation of metabolite concentrations from localized in vivo proton NMR spectra
Provencher, S. W. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300604 · Cited by 3,655
Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder
Saxena, S., & Rauch, S. L. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70181-7 · Cited by 840
Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging
Magistretti, P. J., & Pellerin, L. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0471 · Cited by 749
Auer, D. P., Pütz, B., Kraft, E., Lipinski, B., Schill, J., & Holsboer, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00159-6 · Cited by 564
ROSENBERG, D. R., MacMASTER, F. P., KESHAVAN, M. S., FITZGERALD, K. D., STEWART, C. M., & MOORE, G. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200009000-00008 · Cited by 377
Obsessive-Compulsive and Spectrum Disorders in Children and Adolescents
Geller, D. A. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.02.012 · Cited by 369
Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder
Arnold, P. D., Sicard, T., Burroughs, E., Richter, M. A., & Kennedy, J. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.769 · Cited by 357
Research works printed but not linked: 3
- Wechsler D, 1999, Wechsler Abbreviated Scale of Intelligence manual
- Free SL, 1995, AJNR Am J Neuroradiol, 16, 637
- Cohen JD, 1988, Statistical power analysis for the behavioral sciences2nd ed
Cited by
Pittenger, C., Bloch, M. H., & Williams, K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.006 · Cited by 426
“A reduction in ACC Glx that correlated with symptom severity was replicated in one MRS study in adults with OCD, though only in women (Yucel et al., 2008); a second study in adults found no difference between OCD patients and controls in ACC Glx (Starck et al.”
BackgroundResultInfluentialThe role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder
Wu, K., Hanna, G. L., Rosenberg, D. R., & Arnold, P. D. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.007 · Cited by 264
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript cingulate cortex (ACC) Glx in pediatric and adult OCD patients regardless of medication status (Rosenberg et al., 2004; Yucel et al 2008).”
Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?
Allen, P. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.03.005 · Cited by 163
Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder
Bhattacharyya, S., Khanna, S., Chakrabarty, K., Mahadevan, A., Christopher, R., & Shankar, S. K. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.77 · Cited by 172
“Similarly, there were significantly more bands, suggesting binding of CSF autoantibodies to homogenate of thalamus corresponding to molecular weight of 97, 43, and between 6.5 and 3 kD, among OCD patients compared with controls.”
BackgroundResultInfluentialA Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder
Stewart, S. E., Jenike, E. A., Hezel, D. M., Stack, D. E., Dodman, N. H., Shuster, L., & Jenike, M. A. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c856de · Cited by 158
Metadata
- Authors
- Yücel, M., Wood, S. J., Wellard, R. M., Harrison, B. J., Fornito, A., Pujol, J., Velakoulis, D., & Pantelis, C.
- Affiliations
- Orygen (AU)
- The University of Melbourne (AU)
- Queensland University of Technology (AU)
- IAT-PRBB, CRC Corporation, Hospital del Mar, Barcelona, Spain
- Corresponding author
- Yücel, Murat
- ORCID
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2008-01-01
- Volume
- 42
- Issue
- 6
- Pages
- 467-477
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2142016029
- Cited by
- 130
- References
- 40
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 2 · 2023: 9 · 2022: 4 · 2021: 8 · 2020: 6 · 2019: 7 · 2018: 6 · 2017: 6 · 2016: 9 · 2015: 9 · 2014: 6 · 2013: 9 · 2012: 10
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.informaworld.com
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- QUT ePrints (Queensland University of Technology) (submittedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression (509345)
- David and Elaine Potter Foundation
- Ian Potter Foundation
- Medical Research Council
- National Health and Medical Research Council (400420, 236175)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- obsessive-compulsive disorder, anterior cingulate cortex, glutamate/glutamine, symptom severity, gender differences, 1H NMR, myo-inositol, N-acetylaspartate, choline-containing compounds, creatine/phosphocreatine, neurochemistry, treatment monitoring
- MeSH terms
- Adult, Aspartic Acid, Choline, Creatine, Female, Glutamine, Gyrus Cinguli, Humans, Inositol, Male, Neuropsychological Tests, Magnetic Resonance Spectroscopy, Obsessive-Compulsive Disorder, Predictive Value of Tests, Severity of Illness Index, Sex Factors, Biomarkers, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anterior Cingulate Glutamate–Glutamine Levels Predict Symptom Severity in Women With Obsessive–Compulsive Disorder. https://app.cochat.ai/papers/10.1080/00048670802050546
- The paper
- Yücel, M., Wood, S. J., Wellard, R. M., Harrison, B. J., Fornito, A., Pujol, J., Velakoulis, D., & Pantelis, C. (2008). Anterior Cingulate Glutamate–Glutamine Levels Predict Symptom Severity in Women With Obsessive–Compulsive Disorder. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/00048670802050546
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.